Brief: AFT Pharmaceuticals Declares Final Dividend of 2.5 NZ Cents Per Share
20/05/2026 21:53
May 21 (Reuters) - AFT Pharmaceuticals - FINAL Dividend of 2.5 NZ cents per share declared. FY revenue NZD 254.7 million FY EBIT NZD 24.4 MILLION FY NET DEBT NZD 38.6 MILLION FY NET INCOME NZD 14.1 MILLION FY EBITDA NZD 28.8 MILLION
Recent news on AFT Pharmaceuticals
See all newsNZ's AFT Pharma eyes highest weekly gain in over 2 months after results
Brief: AFT Pharmaceuticals Reports Double Digit Revenue Growth In 1H FY27
NZ's AFT Pharmaceuticals gains most in over 2 weeks on strong half-year results
Brief: AFT Pharmaceuticals Enters Exclusive Development, License And Supply Agreement With Mikasaseiyaku
NZ's AFT Pharma rises to near 1-month high on Japan licensing deal for Maxigesic IV